Literature DB >> 29859852

FLT3 inhibitors for relapsed or refractory acute myeloid leukaemia.

Eytan M Stein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29859852     DOI： 10.1016/S1470-2045(18)30335-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Prognosis and outcome of patients with acute myeloid leukemia based on FLT3-ITD mutation with or without additional abnormal cytogenetics.

Authors:  Shandong Tao; Chunling Wang; Yue Chen; Yuan Deng; Lixiao Song; Yuyue Shi; Lanlan Ling; Banghe Ding; Zhengmei He; Liang Yu
Journal:  Oncol Lett       Date:  2019-11-05       Impact factor: 2.967

2.  Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.

Authors:  Jieping Li; Li Yang; Rui Shen; Li Gong; Zhiqiang Tian; Huarong Qiu; Zhe Shi; Lichen Gao; Hongwu Sun; Guangsen Zhang
Journal:  J Nanobiotechnology       Date:  2018-10-05       Impact factor: 10.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.